Who will benefit from ACE inhibition? - a podcast by BMJ Group

Alistair Lindsay talks to Leong Ng about his work into using biomarkers to identify which groups of patients will benefit from ACE inhibition after acute coronary syndrome.

See also:

Identification of potential outcome benefit from ACE inhibition after acute coronary syndrome: a biomarker approach using N-terminal proBNP http://bit.ly/11hAfKc

Further episodes of Heart podcast

Further podcasts by BMJ Group

Website of BMJ Group